Putting an end to rheumatoid arthritis?

Illustration zur Auflösung von Entzündung.
Grafik: Lehrstuhl für Genetik

Interdisciplinary research team unlocks the mechanism for inhibiting inflammation of the joints.

Immunoglobulin G antibodies (IgB) play an important role as drivers of inflammation in infectious diseases and autoimmune diseases. However, if the same immunoglobulin antibodies from the blood plasma of healthy donors are cleansed and injected into a patient’s bloodstream, they exhibit anti-inflammatory effects and have a positive effect on the immune system. The cause of this was unknown to a large extent up to now.

An interdisciplinary team of researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and the universities of Ulm and Würzburg led by Prof. Falk Nimmerjahn (Chair of Genetics at FAU) has now unlocked the mechanism that causes these intravenous immunoglobulin antibodies to resolve joint inflammation in rheumatoid arthritis. The researchers have published their findings in the journal Immunity.

The results indicate that antibodies from healthy donors, also known as intravenous immunglobulin antibodies, or IVIg for short, are able to suppress a central self-destructive process of rheumatoid arthritis – the degeneration and remodeling of bones and cartilage tissue in joints. “This bone degeneration caused by the inflammatory reaction leads to severe damage of the joints in patients of rheumatoid arthritis,” explains Prof. Nimmerjahn. “The results of the study now show for the first time how this process is suppressed on the molecular level by antibodies.” What surprised the interdisciplinary research team most of all was that molecules usually associated with fighting off pathogens such as bacteria and fungi play a central role for the anti-inflammatory effect of intravenous immunoglobulin antibodies. If these receptors were missing, the antibodies could no longer protect against inflammation and bone loss. These findings are of great importance for the development of new therapies for autoimmune diseases and inflammation triggered by cytokines and autoantibodies.

Collaboration with leading experts in the atomistic simulation of receptors and cell membranes (Prof. Rainer Böckmann, FAU), who benefited from the optimal environment of the Center for National High Performance Computing Erlangen (NHR@FAU), was essential for this interdisciplinary study. Collaboration with the world’s leading researchers in the field of high-resolution microscopy (super resolution microscopy) led by Prof. Markus Sauer (University of Würzburg) was equally as important. The research was carried out with funding from the DFG as part of CRC 1181 ( Checkpoints for Resolution of Inflammation; speaker Prof. Georg Schett, FAU).

Wissenschaftliche Ansprechpartner:

Prof. Dr. Falk Nimmerjahn
Chair of Genetics




Media Contact

Blandina Mangelkramer Presse und Kommunikation
Friedrich-Alexander-Universität Erlangen-Nürnberg

All latest news from the category: Interdisciplinary Research

News and developments from the field of interdisciplinary research.

Among other topics, you can find stimulating reports and articles related to microsystems, emotions research, futures research and stratospheric research.

Back to home

Comments (0)

Write a comment

Newest articles

Researchers show an old law still holds for quirky quantum materials

This surprising result is important for understanding unconventional superconductors and other materials where electrons band together to act collectively. Long before researchers discovered the electron and its role in generating…

Straining memory leads to new computing possibilities

Researchers develop hybrid phase-change memristors that offer fast, low-power, and high-density computing memory.# By strategically straining materials that are as thin as a single layer of atoms, University of Rochester scientists have…

A patch of protection against Zika virus

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus. A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch…

Partners & Sponsors